1. Oshima, Shinichiro, Sinha, Rahul, Ohno, Mikiko, Nishi, Eiichiro, Yamamoto, Ryo. 2023. Nardilysin determines hematopoietic stem cell fitness by regulating protein synthesis. In Biochemical and biophysical research communications, 693, 149355. doi:10.1016/j.bbrc.2023.149355. https://pubmed.ncbi.nlm.nih.gov/38096617/
2. Kanda, Keitaro, Sakamoto, Jiro, Matsumoto, Yoshihide, Nishi, Eiichiro, Seno, Hiroshi. 2018. Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation. In JCI insight, 3, . doi:10.1172/jci.insight.91316. https://pubmed.ncbi.nlm.nih.gov/29669932/
3. Ikuta, Kozo, Fukuda, Akihisa, Ogawa, Satoshi, Nishi, Eiichiro, Seno, Hiroshi. 2018. Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. In Gut, 68, 882-892. doi:10.1136/gutjnl-2017-315425. https://pubmed.ncbi.nlm.nih.gov/29798841/
4. Fu, Jie, Ling, Jianhua, Li, Ching-Fei, Lin, Chunru, Chiao, Paul J. 2024. Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. In Nature communications, 15, 3149. doi:10.1038/s41467-024-47242-3. https://pubmed.ncbi.nlm.nih.gov/38605037/
5. Fujii, Takayuki, Nishi, Eiichiro, Ito, Hiromu, Kimura, Takeshi, Matsuda, Shuichi. 2017. Nardilysin is involved in autoimmune arthritis via the regulation of tumour necrosis factor alpha secretion. In RMD open, 3, e000436. doi:10.1136/rmdopen-2017-000436. https://pubmed.ncbi.nlm.nih.gov/28955486/
6. Morita, Yusuke, Ohno, Mikiko, Nishi, Kiyoto, Kimura, Takeshi, Nishi, Eiichiro. 2017. Genome-wide profiling of nardilysin target genes reveals its role in epigenetic regulation and cell cycle progression. In Scientific reports, 7, 14801. doi:10.1038/s41598-017-14942-4. https://pubmed.ncbi.nlm.nih.gov/29093577/
7. Kasai, Yosuke, Toriguchi, Kan, Hatano, Etsuro, Uemoto, Shinji, Nishi, Eiichiro. 2017. Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3. In Cancer science, 108, 910-917. doi:10.1111/cas.13204. https://pubmed.ncbi.nlm.nih.gov/28207963/
8. Nishi, Kiyoto, Sato, Yuichi, Ohno, Mikiko, Kimura, Takeshi, Nishi, Eiichiro. 2016. Nardilysin Is Required for Maintaining Pancreatic β-Cell Function. In Diabetes, 65, 3015-27. doi:10.2337/db16-0178. https://pubmed.ncbi.nlm.nih.gov/27385158/
9. Kodama, Michiko, Shimura, Hiroko, Tien, Jean C, Jenkins, Nancy A, Copeland, Neal G. 2021. Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma. In Cancer research, 81, 5413-5424. doi:10.1158/0008-5472.CAN-21-0356. https://pubmed.ncbi.nlm.nih.gov/34475109/
10. Yoh, Tomoaki, Hatano, Etsuro, Kasai, Yosuke, Uemoto, Shinji, Nishi, Eiichiro. 2018. Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection. In Clinical cancer research : an official journal of the American Association for Cancer Research, 25, 619-628. doi:10.1158/1078-0432.CCR-18-0124. https://pubmed.ncbi.nlm.nih.gov/30352908/